| http://www.w3.org/ns/prov#value | - ???One of the most important observations from SAMMPRIS is that in keeping with findings from multiple other cardiovascular trials, the great progress in terms of event reduction achieved in the past decade by medical therapy also applies to symptomatic intracranial atherosclerotic disease,??? said Tudor G. Jovin, M.D., director of the UPMC Stroke Institute and co-principal investigator of the UPM
|
